Tag Archives | Biogen Inc.

Biogen (BIIB): Proxy Score 47 – Proxy Access Victory

Biogen Inc. (BIIB) discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. It is one of the stocks in my portfolio. Their annual meeting is coming up on 6/10/2015. ProxyDemocracy.org had the vote of five funds (removed 2nd Calvert from table below, since it was duplicative) when I checked and voted […]

Continue Reading ·

Powered by WordPress. Designed by WooThemes